חזרה לתוצאות החיפוש

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE4

מצבים רפואיים

Multiple Sclerosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Yale School of Medicine, New Haven, Connecticut, United States

    Contact: Study coordinator (Katerina Palma) · Katerina.palma@yale.edu
    Contact: Principal Investigator (Erin Longbrake)

  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (David Pisfil) · ddp39@georgetown.edu · 202-444-4289
    Contact: Principal Investigator (Benjamin Osborne, MD)

  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Caroline Gebczak) · caroline.gebczak@northwestern.edu · 630-313-0470
    Contact: Study coordinator (Dylan Rice) · dylan.rice@northwestern.edu · 240-362-4800
    Contact: Principal Investigator (Farrah Mateen, MD)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Aisha Seard) · aseard@mgh.harvard.edu · 617-726-7565
    Contact: Principal Investigator (Michael Levy, MD)

  • University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

    Contact: Study coordinator (Irina Radu) · irina.radu@umassmed.edu · 774-520-4435
    Contact: Study coordinator (Mariana Kurban) · mariana.kurban@umassmed.edu · (774) 519-2005
    Contact: Principal Investigator (Carolina Ionete)

  • RWJ Barnabas Health, Livingston, New Jersey, United States

    Contact: Study coordinator (Joshua-Daniel Bishop-Mbachu) · Joshua-Daniel.Bishop-Mbachu@rwjbh.org · 973-322-7509
    Contact: Principal Investigator (Matthew Tremblay, MD)

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Nicole Graziano) · nicole.graziano@mssm.edu · 212-241-3391
    Contact: Principal Investigator (Aaron Miller)

  • University of Rochester Medical Center, Rochester, New York, United States

    Contact: Study coordinator (Jennifer Voelkl) · jenniferm_voelkl@urmc.rochester.edu · 585-276-3513
    Contact: Principal Investigator (Andrew Goodman)

  • Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Kellie Kraus) · kellie-kraus@omrf.org · 405-271-7135
    Contact: Principal Investigator (Gabriel Pardo)

  • University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Kristen Fleming) · Kristen.fleming@pennmedicine.upenn.edu
    Contact: Principal Investigator (Amit Bar-Or)

  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Manuel Huichapa) · manuel.huichapa@utsouthwestern.edu · 214-645-8216
    Contact: Principal Investigator (Ben Greenberg)

  • The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States

    Contact: Study coordinator (Tanya Khan) · Tanya.S.Khan@uth.tmc.edu · 713-704-0823
    Contact: Principal Investigator (John Lindsey, MD)

  • Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States

    Contact: Study coordinator (Aarati Pokharel) · Aarati.Pokharel@vcuhealth.org · 540-394-1373
    Contact: Principal Investigator (Ryan Canissario, MD)
    Contact: Principal Investigator (Myla Goldman, MD)
מובילי המחקר

  • Amit Bar-Or, M.D.

    Study Chair

    University of Pennsylvania, Perelman School of Medicine: Department of Neurology

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)